.svg){kind=small}
Oct-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Is this your brand?
See your full sales and distribution data: where you sell, how you're priced, and how you rank against the brands next to you on the shelf.
See your brand's dataCarry this brand in your store?
Headset Retailer is free. Connect your POS and see what's selling and what's sitting.
Sign up freeMarket Insights Snapshot
In October 2026, MediPharm Labs concentrated 88.16% of sales in Oil, where year-over-year declined 39.84% and month-over-month fell 19.49%, while Vapor Pens rose to 9.70% share with a 34.23% MoM increase despite a 20.06% YoY drop. Capsules slipped to 1.62% share with a 31.11% MoM contraction and a 16.73% YoY decline, and Edible contracted to 0.51% share with a 90.92% YoY decrease even as MoM edged up 6.09%. With brand-level YoY sales down 39.87% and average price down 2.24%, the mix shift implies reliance on Oil is amplifying volatility, while Vapor Pens’ MoM rebound provides the only near-term counterweight.
The category pivot suggests MediPharm Labs is moving from a single-category identity toward a dual-rail proposition, as Oil at 88.16% share compresses under a 19.49% MoM pullback while Vapor Pens’ 34.23% MoM surge supplies incremental headroom. Given Oil’s rank position at 3 in Alberta and the brand’s top market in ON, the pattern implies geographic and form-factor concentration risk; sustaining the 9.70% share in Vapor Pens while rehabilitating Capsules’ 31.11% MoM retreat could buffer against a 39.87% YoY brand decline. Net, the mix signals that stabilizing Oil while nurturing the higher-velocity Vapor Pens pocket is the clearest path to moderating the 56.90% 24‑month slide.
Competitive Landscape
MediPharm Labs sits at rank #3 in ON Oil in October 2026, unchanged from #3 year over year, and also flat versus three months ago at #3; this stability contrasts with Mod holding #1 both this year and last while growing sales by 22.2%, and Redecan staying at #2 despite a 3.3% sales decline year over year, indicating MediPharm Labs is neither gaining on the leader nor being displaced by the runner-up. MediPharm Labs remains below its peak of #2 last reached in December 2024, while NightNight stays at #4 with 21.8% YoY sales growth and ufeelu improved from #6 to #5 with 11.9% YoY sales growth, suggesting that faster-growing brands are pressing from below while a flat rank implies share preservation rather than expansion.
Notable Products
MediPharm Labs is highly concentrated in Oils, with Hybrid and CBD oils combining for 88.1% of October 2026 sales, and the top 10 items covering 94.1%. The CBN:THC 1:2 Nighttime Formula Oil (30ml) alone holds 32.1%, so most of its sales ride on a small set of oil SKUs.
Peer avg: average price of the same product type and package size in the same states that month.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
